R&D Systems™ Recombinant Human IL-21R Fc Chimera Protein

Catalog No.	Quantity
991R2100	100 μg

Catalog No. 991R2100 Supplier R&D Systems™ Supplier No. 991R2100

Description

Extensive quality control produces industry leading bioactivity and lot-to-lot consistency that instills confidence in results and ensures reproducibility. Applications: Bioactivity

The Recombinant Human IL-21 R Fc Chimera Protein is derived from NS0. The Recombinant Human IL-21 R Fc Chimera Protein has been validated for the following applications: Bioactivity.

Specifications

• Formulation: Lyophilized from a 0.2μm filtered solution in PBS.
• Gene ID (Entrez): 50615
• Molecular Weight (g/mol): 51.7 kDa (monomer)
• Name: IL-21R
• Quantity: 100 μg
• Source: Mouse myeloma cell line,NS0-derived human IL-21 R protein, (N-terminus) Human IL-21 R Subunit (Cys20-Pro236) Accession &Num; Q9HBE5 DIEGRMD Human IgG1 (Pro100-Lys330) (C-terminus)
• Storage Requirements: Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70° C as supplied. 1 month, 2 to 8° C under sterile conditions after reconstitution. 3 months, -20 to -70° C under sterile conditions after reconstitution.
• Structural Form: Disulfide-linked homodimer
• Endotoxin Concentration: <0.1 EU per 1μg of the protein by the LAL method.
• Gene Alias: CD360, CD360 antigen, IL-21 R, IL-21 receptor, IL21R, IL-21R, interleukin 21 receptor, interleukin-21 receptor, MGC10967, NILR, Novel interleukin receptor
• Conjugate: Unconjugated
• Recombinant: Recombinant
• Purity or Quality Grade: 95%, by SDS-PAGE under reducing conditions and visualized by silver stain.